Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 11

    1.

    Assessment of outcome predictors after first attack of optic neuritis.

    Mamarabadi M, Razjouyan H, Mohammadi F, Moghaddasi M.

    Can J Neurol Sci. 2011 Nov;38(6):887-95.

    PMID:
    22030428
    [PubMed - indexed for MEDLINE]
    2.

    Aberrant expression of the apoptosis-related proteins BAK and MCL1 in T cells in multiple sclerosis.

    Mandel I, Paperna T, Miller A.

    J Neuroimmunol. 2012 Mar;244(1-2):51-6. Epub 2012 Jan 16.

    PMID:
    22257632
    [PubMed - indexed for MEDLINE]
    3.

    Analysis of antibodies to surface epitopes of contactin-2 in multiple sclerosis.

    Boronat A, Sepúlveda M, Llufriu S, Sabater L, Blanco Y, Gabilondo I, Solà N, Villoslada P, Dalmau J, Graus F, Saiz A.

    J Neuroimmunol. 2012 Mar;244(1-2):103-6. Epub 2012 Jan 14.

    PMID:
    22245283
    [PubMed - indexed for MEDLINE]
    4.

    Polysomnographic measures of disturbed sleep are associated with reduced quality of life in multiple sclerosis.

    Trojan DA, Kaminska M, Bar-Or A, Benedetti A, Lapierre Y, Da Costa D, Robinson A, Cardoso M, Schwartzman K, Kimoff RJ.

    J Neurol Sci. 2012 May 15;316(1-2):158-63. Epub 2012 Jan 16.

    PMID:
    22251932
    [PubMed - in process]
    5.

    Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosis.

    Avsar T, Korkmaz D, Tütüncü M, Demirci NO, Saip S, Kamasak M, Siva A, Turanli ET.

    Mult Scler. 2012 Jan 17. [Epub ahead of print]

    PMID:
    22252467
    [PubMed - as supplied by publisher]
    6.

    No proinflammatory signature in CD34+ hematopoietic progenitor cells in multiple sclerosis patients.

    Lutterotti A, Jelcic I, Schulze C, Schippling S, Breiden P, Mazzanti B, Reinhardt S, Di Gioia M, Repice A, Massacesi L, Sputtek A, Salinas-Riester G, Kroeger N, Sospedra M, Saccardi R, Zander A, Martin R.

    Mult Scler. 2012 Jan 17. [Epub ahead of print]

    PMID:
    22252466
    [PubMed - as supplied by publisher]
    7.

    Subcutaneous administration of alemtuzumab in patients with highly active multiple sclerosis.

    Perumal JS, Foo F, Cook P, Khan O.

    Mult Scler. 2012 Jan 17. [Epub ahead of print]

    PMID:
    22252465
    [PubMed - as supplied by publisher]
    8.

    Systematic review of disease-modifying therapies to assess unmet needs in multiple sclerosis: tolerability and adherence.

    Giovannoni G, Southam E, Waubant E.

    Mult Scler. 2012 Jan 16. [Epub ahead of print]

    PMID:
    22249762
    [PubMed - as supplied by publisher]
    9.

    Vitamin D and multiple sclerosis: an interaction between genes and environment.

    Handel AE, Ramagopalan SV.

    Mult Scler. 2012 Jan;18(1):2-4. No abstract available.

    PMID:
    22247498
    [PubMed - indexed for MEDLINE]
    10.

    Corrigendum to Multiple sclerosis: BAFF and CXCL13 in cerebrospinal fluid.

    Galimberti D.

    Mult Scler. 2012 Jan 13. [Epub ahead of print] No abstract available.

    PMID:
    22247426
    [PubMed - as supplied by publisher]
    11.

    Multiple sclerosis: 'Outside-in' demyelination in MS.

    Malpass K.

    Nat Rev Neurol. 2012 Jan 17;8(2):61. doi: 10.1038/nrneurol.2011.217. No abstract available.

    PMID:
    22249838
    [PubMed - in process]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk